Adenoid Cystic Carcinoma — Trials

Adenoid Cystic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

95 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 17
Ph III recruiting: 0
Growth YoY: —
Industry share: 23%
Top sponsor: Eye & ENT Hospital of Fudan University
Termination share: 27.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04119453	A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)	terminated	Phase 2	80	Elevar TherapeuticsINDUSTRY	2	Jul 30, 2026	clinicaltrials
NCT06322576	177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma	terminated	Phase 2	1	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Jan 22, 2026	clinicaltrials